SEATTLE—Alexandria Real Estate Equities, Inc., the largest and leading REIT uniquely focused on collaborative science campuses in urban innovation clusters, hosted a groundbreaking for Juno Therapeutics, Inc. at the Alexandria Center at 400 Dexter Avenue North for Juno's new headquarters and R&D center, situated in the heart of the vibrant Lake Union cluster.

Lake Union is one of the fastest growing science and technology submarkets. Today, Alexandria is developing an approximately 287,000 square foot state-of-the-art laboratory/office building, which Juno will anchor. Juno is leasing 90,000 square feet with expansion options.

"Today we celebrate the groundbreaking for Juno's Headquarters and R&D Center,” said Joel Marcus, chairman, CEO and founder of Alexandria. “At Alexandria, we are honored to strategically partner with Juno, which is pursuing work in the field of cancer immunotherapy which is destined to change the face of cancer treatment. Juno is a leader in one of the most promising technologies in the field of cancer immunotherapy. We are creating an innovative and collaborative space environment for Juno and its fast growing workforce, which will enhance creativity and discovery. Alexandria and Juno have had a special relationship, and we look forward to continuing to work together to realize the promise of bringing such treatments and cures to cancer patients everywhere."